Breaking News

Pharmalogic Acquires Majority Stake in Agilera Pharma

Enhances its capabilities across development, manufacturing, and global distribution of commercial and clinical therapeutic radiopharmaceuticals.

Author Image

By: Charlie Sternberg

Associate Editor

PharmaLogic Holdings Corp., a contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, has completed its previously announced acquisition of a majority stake in Agilera Pharma AS from the Institute for Energy Technology (IFE) in Norway. “The addition of Agilera’s capabilities to PharmaLogic marks a key milestone in our expansion strategy into radiopharmaceutical therapeutics,” said Etienne Montagut, President and CEO of PharmaLogic. &#8...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters